Our study showed that LPM achieved good clinical efficacy in treating LDH, according to the VAS and JOA scores. Clinically, the scales most commonly used to evaluate this treatment are VAS, JOA, Oswestry disability index (ODI), Self-Rating Anxiety Scale (SAS), and Self-rating depression scale (SDS), amongst others. Among them, VAS and JOA are most commonly used to evaluate the efficacy of LDH treatment, ODI is often used to evaluate before and after surgery, and SAS and SDS are often used to evaluate the emotional and mental disorders associated with this disease. Since LPM is a non-surgical treatment, the present study did not explore the factors of mental and emotional disorders. Therefore, VAS and JOA were used as the main clinical indicators to evaluate this treatment in this study. In addition, the goal of treatment for LDH is to correct the herniated disc structurally, relieve the symptoms of pain functionally, and improve the state of anxiety psychologically. Therefore, the gold standard for treating LDH is also judged around the above efficacy. Although, medical institutions often recommend surgery and medication. However, its negative effects are inevitable for doctors and patients to worry about. In contrast, LPM, a green and safe therapy of non-invasive non-drug for LDH, is more likely to be widely recognized and meets the gold standard of therapeutic approaches (Dhatt et al., 2011).
This study explored the effect of LPM on brain function in patients with LDH through fMRI technology and obtained significant results. As MRI is a sensitive imaging method, different intervention methods (Toffoletto et al., 2014), pathological states (Hauzeur et al., 1992), and measurement indicators (Takahashi and Grove, 2019) can activate different brain regions. For example, one study showed that conventional tuina therapy could activate the ALFF value of the right lingual gyri in LDH patients (Wen et al., 2022). Another study compared the brain regions of LDH patients with balance acupuncture and body acupuncture. Moreover, they found that balance acupuncture could better regulate the function of the endogenous pain regulation network, especially in the bilateral amygdala, while the brain regulation of body acupuncture was not significant (Ye and Liu, 2012). Based on the above, we believe that the significant activation of brain areas in patients with LDH is likely related to the effectiveness of treatment methods and timeliness. Lever positioning manipulation treatment of LDH is effective and highly accepted by patients. Even a single immediate treatment can comfort patients significantly (Lijiang et al., 2012). Therefore, this study focused on the real-time brain activity in patients with LDH after LPM.
This study demonstrated that the ALFF values of patients with LDH were most significantly enhanced in the Precuneus_R but most significantly decreased in the Frontal_Mid_Orb_L compared to healthy controls. The ReHo values of patients with LDH were increased in the Frontal_Mid_R. However, the Frontal_Mid_Orb_L and Frontal_Sup_Orb_L decreased when compared with healthy controls. After the one-LPM session, the degree of pain was relieved. Additionally, large brain areas were significantly activated in ALFF and ReHo values. Frontal_Mid_R is the most significantly enhanced brain area, and Precentral_L is the most significantly decreased brain area.
The Precuneus_R is part of the default mode network (DMN). Furthermore, the Frontal_Mid_Orb_L, Frontal_Mid_R, Frontal_Mid_Orb_L, and Frontal_Sup_Orb_L are part of the prefrontal cortex (PFC). Moreover, the Precentral_L is part of the primary somatosensory cortex (S1). These interconnected brain networks show that activity in the DMN, PFC, and S1 may reflect responses to pain management with LPM in patients with LDH.
The DMN, a network of brain regions active during sleep, is suppressed when specific tasks are involved (Buckner et al., 2008). Typical pain cognitive function depends on maintaining a dynamic equilibrium between the DMN and other brain systems (Uddin et al., 2009). A study by Tan et al. suggests the potential utility of the DMN as a neuroimaging biomarker for pain management in patients with LDH (Tan et al., 2020). Baliki et al. suggest that disruptions of the DMN may underlie the cognitive and behavioral impairments accompanying chronic pain (Baliki et al., 2008). Zhou et al. found that patients with discogenic low back pain and leg discomfort had decreased ALFF values in DMN areas compared to healthy controls (Zhou et al., 2018). In our study, patients with LDH showed more activity than healthy controls in the Precuneus_R. This brain area is one essential part of the DMN. Our results support the notion that in patients with LDH, the DMN contributes to the brain's mechanisms for pain regulation.
The PFC is critical for controlling emotional responses and integrating emotional information (Cabeza and Nyberg, 2000; Miller, 2000; Salzman and Fusi, 2010). When the PFC is activated, the pain signal processing rate is accelerated, thus reducing the effects of pain (Lorenz et al., 2003; Schweinhardt et al., 2009). Ivo et al.'s voxel-based morphometry study revealed significant reductions in grey matter density in the dorsolateral prefrontal cortex (dlPFC), a region connected to the processing and modulation of pain (Ivo et al., 2013). Another study by Čeko et al. found that patients with LDH showed structural changes in white matter in the dlPFC compared with healthy persons (Čeko et al., 2015). In addition, Baliki et al. found that increased frequency fluctuations within the medial PFC were temporally synchronous with spontaneous pain changes in patients during a pain-rating task (Baliki et al., 2011). According to our analysis, patients with LDH showed more significant activity in the Frontal_Mid_Orb_L, Frontal_Mid_R, Frontal_Mid_Orb_L, and Frontal_Sup_Orb_L after one LPM session. These brain areas are part of the PFC. Therefore, our findings are consistent with the idea that the PFC is a neural correlate of LDH and that it plays a role in the analgesic effects of LPM and the brain's pain-emotion-management mechanisms in people with LDH following LPM.
The S1 is one of the important centers responsible for processing exteroceptive body information (Farb et al., 2013). A study by Li et al. reported that patients with LDH showed increased gray matter volume at the bilateral S1s (Li et al., 2018). Furthermore, Wasan et al. discovered that the clinically significant exacerbation of persistent LDH was connected to significant regional blood flow increases inside S1, which is known to activate in response to experimental pain (Wasan et al., 2011). However, their study focused on the brain structure and cerebral blood flow factors of patients with LDH. In contrast, ours focused on the functional brain network of an analgesic factor after an LPM session. In our study, patients with LDH showed more significant activity in the Precentral_L after one LPM session. This brain area is one essential part of the S1. So we infer that the immediate effects of LPM are mainly embodied in the changes of activity in the cognitive and central analgesia network.
There were some limitations to this study. First, our sample size was small and heterogeneous, which hindered our ability to detect minute changes in brain activity. For example, only the ALFF value in the Frontal_Mid_R at TP2 correlated positively with the change rates of JOA scores between TP1 and TP2. The other areas of brain activity and the clinical variables did not significantly correlate, which was unexpected. The small sample size may have contributed to the lack of notable longitudinal within-group changes. It might also result from our rigorous data analysis methodology with multiple comparison corrections. Second, our trial enrolled patients as walk-ins from outpatient pain clinics. Additionally, they often experienced less severe low back pain than patients in an inpatient environment, who might have more incapacitating pain. Third, the LDH group had no long-term follow-up after LPM. Therefore, there was no information on how long the pain was relieved after LPM. Last, we only used ALFF and ReHo as outcome indicators. Although these two indicators can analyze the brain activity in patients with LDH after LPM from the perspective of the activity of neurons in the brain that are not affected by external factors and the consistency of the local functional activities of the brain's various regions, further research needs to be conducted from the perspective of functional connectivity and functional brain networks.
In the future, an additional follow-up assessment, such as a six-month interval assessment, should be obtained to evaluate changes in the brain responses identified in this study. To summarize, future research is required to increase the sample size, regulate the inclusion and exclusion standards, enhance the experimental design plan, and amplify in-depth research indicators.
In conclusion, our study identified significant ALFF and ReHo values alterations in brain activity in the DMN, PFC, and S1 regions of patients with LDH after LPM treatment. These results suggest that DMN, PFC, and S1 regions may be potential biomarkers for assessing real-time brain responses for sensory and emotional pain management.